Orphazyme A/S Operating Income

As of the most recent data (June 2024), ORPH shows a operating income of $-14M. That compares with $-820M in the prior-year period — up 98.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORPH's operating income is now $-14M (was $-820M) — a 98.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Orphazyme A/S is outperforming or lagging.

Tracking ORPH's operating income over time shows whether Orphazyme A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $-14M That compares with $-820M in the prior-year period — up 98.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Orphazyme A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-14M) with ownership activity and broader fundamentals.

Orphazyme A/S's operating income is $-14M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.